Beta Bionics Inc.

BBNX | NASDAQ

Price Alert Chart Builder DCF Calculator

$16.55

-$0.20 (-1.19%)

Nov 2, 2026, 10:13 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.19%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

+9.0 pts

Fundamentals Average

Market Sentiment Neutral

Moat None

Sector Rank #532/1028 (Top 52%)

Full Analysis

Key Statistics

Market Data

Market Cap $744.58M

1D Range

16.30 16.95

52W Range

8.86 31.99

Valuation (TTM)

PE -8.96

PB 1.88

EV/EBITDA -6.15

Valuation (NTM)

Forward PE N/A

Forward PEG -2.32

Price Target $24.67

Cash Flow

FCF Yield -8.8%

SBC Adj. FCF Yield -11.9%

SBC Impact -35.5%

Margins

Gross Margin 58.6%

Operating Margin -72.8%

FCF Margin -51.8%

Growth (CAGR)

Revenue 3Y | 5Y 245.2% | N/A

Dil EPS 3Y | 5Y -17.2% | N/A

FCF 3Y | 5Y -19.8% | N/A

Returns

ROA -18.7%

ROE -27.3%

ROIC -22.4%

Financial Health

Net Cash

$234.1M

Current Ratio 8.92

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals wit...

Sector Healthcare

Industry Medical - Devices

Employees 422

IPO Date Jan 30, 2025

Website www.betabionics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Latest Earnings

Oct 27, 2026

EPS

-$0.52

Beat +0.64%

YoY: -57.58%

REV

$35.51M

Beat +2.26%

YoY: +30.28%

Next Earnings

Feb 16, 2027

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$25.00

Upside

+51.06%

Buy (6)

Hold (3)

Sell (0)

Analyst Details ➞